| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | NEUTRAL | NEUTRAL | BUY | NEUTRAL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 2.22▲ | 2.22▲ | 2.21▲ | 2.24▼ | 2.06▲ |
| MA10 | 2.21▲ | 2.21▲ | 2.23▼ | 2.20▲ | 1.94▲ |
| MA20 | 2.21▲ | 2.23▼ | 2.24▼ | 2.11▲ | 2.13▲ |
| MA50 | 2.21▲ | 2.22▼ | 2.22▲ | 1.96▲ | 2.55▼ |
| MA100 | 2.24▼ | 2.21▲ | 2.18▲ | 2.13▲ | 2.38▼ |
| MA200 | 2.24▼ | 2.15▲ | 2.01▲ | 2.54▼ | 4.29▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.001▲ | -0.001▼ | -0.005▼ | 0.011▲ | 0.038▲ |
| RSI | 55.693▲ | 47.457▼ | 48.784▼ | 56.857▲ | 49.649▼ |
| STOCH | 50.000 | 63.418 | 22.251 | 56.923 | 44.526 |
| WILL %R | -25.000▲ | -53.333 | -66.667 | -35.065 | -40.000 |
| CCI | 116.667▲ | -13.548 | -54.668 | 32.811 | 74.640 |
|
Monday, April 06, 2026 04:18 AM
NRx has received a letter from the FDA Office of Generic Drugs indicating preliminary alignment on labeling for NRx’s preservative-free ketamine ...
|
|
Monday, March 30, 2026 04:29 AM
Hope Therapeutics (subsidiary of NRx Pharmaceuticals, Nasdaq: NRXP) partners with Emobot Health to deploy its AI-powered "Depression Thermometer" across its interventional psychiatry clinic ...
|
|
Monday, March 30, 2026 04:22 AM
Hope Therapeutics (subsidiary of NRx Pharmaceuticals, Nasdaq: NRXP) partners with Emobot Health to deploy its AI-powered 'Depression Thermometer' ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 10/04/26 | 2.27 | 2.285 | 2.185 | 2.22 | 477,500 |
| 09/04/26 | 2.25 | 2.29 | 2.21 | 2.26 | 393,638 |
| 08/04/26 | 2.35 | 2.35 | 2.18 | 2.25 | 703,344 |
| 07/04/26 | 2.25 | 2.2547 | 2.11 | 2.23 | 699,756 |
| 06/04/26 | 2.22 | 2.302 | 2.21 | 2.25 | 693,089 |
| 02/04/26 | 2.13 | 2.235 | 2.115 | 2.20 | 355,907 |
| 01/04/26 | 2.15 | 2.24 | 2.15 | 2.16 | 417,643 |
| 31/03/26 | 2.07 | 2.20 | 2.07 | 2.13 | 439,823 |
| 30/03/26 | 2.18 | 2.2361 | 2.06 | 2.09 | 653,344 |
| 27/03/26 | 2.30 | 2.3174 | 2.1415 | 2.19 | 863,533 |
|
|
||||
|
|
||||
|
|